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Abstract
Introduction Bariatric procedures result in massive weight
loss, however, not without side effects. Gastric acid is known
to cause marginal ulcers, situated in the small bowel just distal
to the upper anastomosis. We have used the wireless
BRAVO™ system to study the buffering effect of the duode-
nal bulb in duodenal switch (DS), a procedure in which the
gastric sleeve produces a substantial amount of acid.
Methods We placed a pre- and a postpyloric pH capsule in 15
DS-patients (seven men, 44 years, BMI 33) under endoscopic
guidance and verified the correct location by fluoroscopy.
Patients were asked to eat and drink at their leisure, and to
register their meals for the next 24 h.
Results All capsules but one could be successfully placed,
without complications. Total registration time was 17.2 (1.3–
24) hours prepyloric and 23.1 (1.2–24) hours postpyloric, with
a corresponding pH of 2.66 (1.74–5.81) and 5.79 (4.75–7.58),
p < 0.01. The difference in pH between the two locations was
reduced from 3.55 before meals to 1.82 during meals,
p < 0.01. Percentage of time with pH < 4 was 70.0 (19.9–
92.0) and 13.0 (0.0–34.6) pre and postpylorically, demonstrat-
ing a large buffering effect.
Conclusion By this wireless pH-metric technique, we could
demonstrate that the duodenal bulb had a large buffering
effect, thus counteracting the large amount of gastric acid
passing into the small bowel after duodenal switch. This phys-
iologic effect could explain the low incidence of stomal ulcers.
Keywords Bariatric surgery . Duodenal switch .Marginal
ulcer . pH-metry
Introduction
Compared to conservative methods, bariatric surgery provides
sustainable weight loss, high resolution of comorbidities and
decreased overall mortality [1]. The development of bariatric
surgery has been experimental, and today several different
procedures are used. Roux-en-Y gastric bypass (RYGBP) is
commonly performed and considered gold standard by many
authors [2]. Another procedure, duodenal switch (DS), is
used, preferably in patients with super obesity (body mass
index, BMI, over 50 kg/m2), and yields remarkable weight
loss in this group of patients [3, 4]. DS consists of two differ-
ent parts. First, a gastric tube is created by preforming a ver-
tical sleeve gastrectomy to reduce the volume of ingested
food. The duodenal bulb is divided two to 4 cm distal to the
pylorus and anastomosed to the last 2.5-m of distal ileum
(alimentary limb). Second, the remaining small bowel, carry-
ing bile and pancreatic juice, is anastomosed 1 m from the
ileocecal valve, resulting in decreased uptake of ingested
nutrients.
All bariatric procedures have side effects because of major
changes in gastrointestinal physiology. The connection of
stomach and its acid-producing mucosa to the small bowel
can result in marginal ulcers, an ulcer situated just distal to
the anastomosis. The incidence of marginal ulcer ranges be-
tween 0.6 and 16% after RYGBP [5, 6], while it is substan-
tially less frequent in patients having had DS around 0.3% [4].
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As the gastric sleeve in DS contains a much larger amount of
acid-producing gastric mucosa than the small gastric pouch in
RYGBP, the differences in marginal ulcer incidence could be
viewed as paradoxical. The role of included duodenal bulb in
this has not been investigated.
Different pH-measuring systems exist, for instance the
classic catheter-based technique and the wireless BRAVO™
capsule. The BRAVO™ system (Given Imaging, Yokneam,
Israel), developed to measure pH in gastro-esophageal reflux
disease, has the advantage of longer registration time [7–10],
without disturbing the patient’s daily habits. Moreover,
intragastric and duodenal pHmonitoring has been implement-
ed with BRAVO™ system with good reliability and promis-
ing results [11–17]. We have previous experience in measur-
ing pH in the jejunum, just below the level of gastrojejunal
anastomosis in RYGBP, where pH was below four in 10.5
(0.3–37.7) percent of the time during more than 24 h of con-
tinuous registration [18].
The aim of the present study was to study the acidity above
and below the duodenoileostomy inDS bymeasuring pre- and
postpyloric pH during 24 h of normal activity.
Materials and Methods
Fifteen patients (seven men, 44 (25–56) years, BMI 33 (25–
41) kg/m2) who had undergone DS more than 1 year earlier
were recruited at our center. All patients were free of abdom-
inal symptoms and medication, except one patient in whom
PPI-treatment for gastro-esophageal reflux was discontinued
2 weeks before the study. The study was performed at our
endoscopic unit in November 2011–February 2014. Awritten
consent was obtained from all participants.
After a fasting period of at least 6 h, a cannula was put
in the patient’s right arm and a blood sample taken for
Helicobacter pylori and f- serum gastrin. Prior to upper
endoscopy, two wireless BRAVO™ capsules were calibrat-
ed and diazepam offered as sedative. With the patient lying
on the left side, the delivery system of the first capsule was
inserted transorally and followed by the endoscope, to al-
low direct visual control. To enhance passage through the
pylorus, the soft tip of delivery system was grasped by an
endoscopic snare. The capsule was placed 1–2 cm below
the duodenoileostomy and fastened to the mucosa accord-
ing to the manufacturer’s instructions, i.e., activating the
locking pin after 1 min of suction with 550 mmHg, (Fig.1).
After removing the delivery system and endoscope, the
prepyloric capsule was placed in the same way, 5 cm oral
to pylorus. The correct placement of the capsules was con-
firmed by fluoroscopy with patient lying in the supine po-
sition (Fig.2). The wireless pH recording was activated and
patients were asked to carry the portable receiver in a band
over the shoulder. Patients were also asked to press a
specific button on the receiver whenever ingesting some-
thing and to record the meal in a paper protocol. During the
24-h registration, patients were encouraged to eat at their
leisure. The location of the capsules was verified by repeat-
ed fluoroscopy when the patient returned the recording
device on the following day.
pH data was uploaded to the Polygram NET version
4.2 (Given Imaging, Yokneam, Israel). Sudden change in
the pH curve with consistently neutral pattern or loss of
signal indicated the detachment of the capsule (Fig.2).
The total registration time before the detachment of the
capsule, median pH during the total registration time, per-
centage of time with pH < 4, as well as pH 30 min im-
mediately before and during meals, were registered. The
difference in mean pH before and during meals was then
calculated. All measurements were performed individually
by two examiners, and discussed if any inconsequence
occurred.
Statistics
Results are presented as median and range, unless otherwise
specified. Mean pH pre and postpylorically was calculated
during the whole time of registration for each patient. Time
of registration, pH, mean percentage of time with pH < 4 and
difference in pH before and during meals were compared
using Wilcoxon matched-pair signed rank test. A p value
<0.05 was considered significant. Statistical analyses were
performed by using GraphPad Prism 5.0f (GraphPad
Software, Inc., USA).
Results
All capsules, except one postpyloric capsule, could be suc-
cessfully placed and the correct location was verified by fluo-
roscopy. No complications occurred, nor were any complica-
tions reported during the pH-registration.
There was no significant difference in registration time pre-
and postpylorically (17.2 vs. 23.1, p = 0.36). A lower pH was
seen in the gastric tube compared to the postpyloric site, 2.66
(1.74–5.81) vs. 5.79 (4.75–7.58), p < 0.01. When calculating
percentage of time with pH < 4, the same difference in acidity
was apparent, 70.0% (19.9–92.0) and 13.0% (0.0–34.6), re-
spectively, p < 0.01. The difference in pH between the two
locations was reduced from 3.55 before meals to 1.82 during
meals, p < 0.01 (Table 1, Fig. 3).
Serology for H pylori was negative in all patients. Serum
gastrin varied between <10 and 28 pmol/L (reference interval
<55), and was thus within normal interval in all patients. No
correlation was seen to the measured pH levels.
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Discussion
In this pH-metric study, we could demonstrate that the duode-
nal bulb has a large buffering effect. Physiologically, this
seems to counteract the large amount of acid-producing mu-
cosa in DS. As expected, the difference between pre- and
postpyloric pHwas reduced duringmeals, when ingested food
increased the gastric pH.
Although conventional placement of the BRAVO™-cap-
sule is done after removal of the endoscope, we used direct
endoscopic guidance to place the two capsules. Direct place-
ment avoids a repeated endoscopy to confirm the placement of
the capsule and is associated with shorter procedure time and
less discomfort for the patients [8, 12, 19]. An acute angula-
tion of the gastric tube imposed some difficulties in advancing
the capsule distally through the pylorus, and the use of an
Fig. 1 Schematic drawing of duodenal switch (DS) with marked positions for the twoBravo capsules. Endoscopic images representing capsules in place
at the pre and postpyloric site
Fig. 2 Confirmation by
fluoroscopy after placement of the
two Bravo capsules and a typical
pH curve
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endoscopic snare was very helpful. The repeated fluoroscopic
examinations, directly after placing the capsule and on the
following morning, verified the correct placement of the
capsules.
Using only suction and the locking pin, we achieved full
24-h registration for four of the prepyloric capsules and seven
postpyloric, corresponding to 26 and 50%, respectively.
Registration time is reported to be increased by securing the
capsule onto the gastric wall by placing an endoscopic
hemoclip on top of a thread tied to the capsule [11, 13, 14].
In our case, registration time was anyhow limited to 24 h, by
allowing all data from the two parallel BRAVO™-capsules to
be recorded on one receiver.When using separate receivers for
each capsule, registration times of up to 48 h onto the gastric
wall has been demonstrated [12], as well as up to 4 days in the
esophagus with two receivers consecutively calibrated to the
same capsule [20].
In our previous measurements, just below the gastrojejunal
anastomosis, in 21 RYGBP-patients, median percentage of
time with pH < 4 was 10.5% [18], compared to 13.0% in the
present study. Although the large gastric remnant in DS results
in high acidity (68.7% of the time with pH < 4), the alkaline
mucus produced by the Brunner’s glands, located in the first
few centimeters of the duodenum, manages to keep the pH in
the small bowel on almost the same level as in RYGBP. The
high amount of excreted bicarbonate ions will immediately
neutralize of the majority of all gastric acid passing into the
duodenum. Moreover, the mucus is known to have a protec-
tive effect against the erosive acidic gastric content on the
underlying endothelium [21, 22]. Theoretically, bile reflux
could also contribute to a reduced ulcer incidence, but in DS
this requires a retrograde flow through 150 cm of the alimen-
tary limb, which seems unlikely. Furthermore, DS has been
described as an operation of choice for pathologic transpyloric
duodenogastric reflux [23]. Finally, the ileal mucosa might be
more resilient to acid exposure compared to the jejunum used
in RYGBP, although these mechanisms remain to be
elucidated.
Intragastric pH is affected by different factors including
meals, day and night time, medication, vagotomy, presence
of H pylori, duodenogastric reflux, and gastrin levels [24]
etc. These physiological variations have studied by both con-
ventional pH measurements and measurements by the Bravo
system [12, 25–27]. During fasting, pH is <4 most of the time
in a healthy stomach. Ingestion of food increases the
intragastric pH as a result of the buffering effect, usually
returning to baseline after 2 h. We could verify the change in
intragastric pH during meals, and in addition, we could dem-
onstrate an increase in postpyloric pH, probably occurring due
Fig. 3 Difference in pre- and
postpyloric pH before and during
six meals
Table 1 Registration time and pH data, presented in median (range)
and SD, in the 15 studied DS patients
Median (range) SD p value
Registration time (h)
Prepyloric 17.2 (1.3–24) 7.3
Postpyloric 23.1 (1.2–24) 7.8 0.36
pH
Prepyloric 2.66 (1.74–5.81) 1.1
Postpyloric 5.79 (4.75–7.58) 0.9 <0.01
Percent of time with pH < 4
Prepyloric 70.0 (19.9–92.0) 19.9
Postpyloric 13.0 (0.0–34.6) 12.3 <0.01
Difference in pH
Before meals 3.55 (1.60–4.85) 0.8
During meals 1.82 (0.36–3.64) 0.8 <0.01
Wilcoxon matched-pair signed rank test was used for all comparisons
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to increased buffering of ingested food passing into the duo-
denal bulb.
The repeated fluoroscopic examinations, directly after
placing the capsule and on the following morning, verifying
the exact location, are among the strengths of the present
study. The possibility for patients to continue with their ordi-
nary life, without having nasogastric catheters, and the possi-
bility to perform detailed measurements, for example before
and after meals have been favorable with the present tech-
nique.We did not achieve full 24-h registrations in all patients,
which could be regarded as a weakness, especially since four
patients had to be excluded from the analysis regarding pH
difference before and during meals.
In conclusion, we could demonstrate that the duodenal bulb
has a large buffering effect, thus counteracting the large
amount of gastric acid passing into the small bowel after du-
odenal switch. This physiologic effect could contribute to the
low incidence of marginal ulcers.
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